Pfizer CEO Battles RFK Jr Over mRNA Vaccine Cancer Concerns

Pfizer CEO Albert Bourla defended Moderna's well-tested mRNA bird flu vaccine amid US government funding cuts, criticizing the decision as unfounded and emphasizing the importance of vaccines, including their potential in cancer treatment. The article also highlights Pfizer's recent breakthrough in colorectal cancer treatment with the drug Braftovi and discusses the political tensions surrounding vaccine funding and safety skepticism.